These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

209 related items for PubMed ID: 23599406

  • 21. The prognostic significance of urinary interleukin 6 in IgA nephropathy.
    Dohi K, Iwano M, Muraguchi A, Horii Y, Hirayama T, Ogawa S, Shiiki H, Hirano T, Kishimoto T, Ishikawa H.
    Clin Nephrol; 1991 Jan; 35(1):1-5. PubMed ID: 2007290
    [Abstract] [Full Text] [Related]

  • 22. Increased excretion of tumor necrosis factor alpha and interleukin 1 beta in urine from patients with IgA nephropathy and Schönlein-Henoch purpura.
    Wu TH, Wu SC, Huang TP, Yu CL, Tsai CY.
    Nephron; 1996 Jan; 74(1):79-88. PubMed ID: 8883024
    [Abstract] [Full Text] [Related]

  • 23. Correlation of serum levels of complement C4a desArg with pathologically estimated severity of glomerular lesions and mesangial hypercellularity scores in patients with IgA nephropathy.
    Sogabe A, Uto H, Kanmura S, Nosaki T, Oyamada M, Tokunaga K, Nishida C, Fukumoto M, Oku M, Nishimoto K, Takenouchi S, Ido A, Shimada Y, Tsubouchi H.
    Int J Mol Med; 2013 Aug; 32(2):307-14. PubMed ID: 23708385
    [Abstract] [Full Text] [Related]

  • 24. Proteomic approach for identification of IgA nephropathy-related biomarkers in urine.
    Prikryl P, Vojtova L, Maixnerova D, Vokurka M, Neprasova M, Zima T, Tesar V.
    Physiol Res; 2017 Sep 22; 66(4):621-632. PubMed ID: 28406696
    [Abstract] [Full Text] [Related]

  • 25. IgA-containing immune complexes in the urine of IgA nephropathy patients.
    Matousovic K, Novak J, Yanagihara T, Tomana M, Moldoveanu Z, Kulhavy R, Julian BA, Konecny K, Mestecky J.
    Nephrol Dial Transplant; 2006 Sep 22; 21(9):2478-84. PubMed ID: 16757497
    [Abstract] [Full Text] [Related]

  • 26. Increased urinary excretion of macrophage-colony-stimulating factor (M-CSF) in patients with IgA nephropathy: tonsil stimulation enhances urinary M-CSF excretion.
    Matsuda M, Shikata K, Wada J, Yamaji H, Shikata Y, Doi A, Kosaka M, Akagi H, Masuda Y, Ohmoto Y, Makino H.
    Nephron; 1999 Sep 22; 81(3):264-70. PubMed ID: 10050079
    [Abstract] [Full Text] [Related]

  • 27. The immunochemical characterization of the light chains in the mesangial IgA deposits in IgA nephropathy.
    Lai KN, Chan KW, Mac-Moune F, Ho CP, Yan KW, Lam CW, Vallance-Owen J.
    Am J Clin Pathol; 1986 May 22; 85(5):548-51. PubMed ID: 3085470
    [Abstract] [Full Text] [Related]

  • 28. Establishment of a 2-D human urinary proteomic map in IgA nephropathy.
    Park MR, Wang EH, Jin DC, Cha JH, Lee KH, Yang CW, Kang CS, Choi YJ.
    Proteomics; 2006 Feb 22; 6(3):1066-76. PubMed ID: 16372274
    [Abstract] [Full Text] [Related]

  • 29. [Expression and clinical implication of platelet-derived growth factor-D and platelet-derived growth factor-beta in childhood IgA nephropathy].
    Rong ZH, Wang C, Hao J, Duan HJ.
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2008 May 22; 20(5):275-8. PubMed ID: 18471357
    [Abstract] [Full Text] [Related]

  • 30. Analysis of the differential urinary protein profile in IgA nephropathy patients of Uygur ethnicity.
    Guo Z, Wang Z, Lu C, Yang S, Sun H, Reziw, Guo Y, Sun W, Yue H.
    BMC Nephrol; 2018 Dec 14; 19(1):358. PubMed ID: 30547763
    [Abstract] [Full Text] [Related]

  • 31. Identification of a uromodulin fragment for diagnosis of IgA nephropathy.
    Wu J, Wang N, Wang J, Xie Y, Li Y, Liang T, Wang J, Yin Z, He K, Chen X.
    Rapid Commun Mass Spectrom; 2010 Jul 30; 24(14):1971-8. PubMed ID: 20552702
    [Abstract] [Full Text] [Related]

  • 32. Urine proteome analysis by C18 plate-matrix-assisted laser desorption/ionization time-of-flight mass spectrometry allows noninvasive differential diagnosis and prediction of diabetic nephropathy.
    Chen CJ, Liao WL, Chang CT, Liao HY, Tsai FJ.
    PLoS One; 2018 Jul 30; 13(7):e0200945. PubMed ID: 30024955
    [Abstract] [Full Text] [Related]

  • 33. [Study on the predictors for superimposed preeclampsia in patients with IgA nephropathy].
    Suetsugu Y, Tokudome G, Sugano N, Yoshizawa T, Endo S, Hara Y, Takane K, Kuriyama S, Hosoya T.
    Nihon Jinzo Gakkai Shi; 2011 Jul 30; 53(8):1139-49. PubMed ID: 22351992
    [Abstract] [Full Text] [Related]

  • 34. Urinary Exosomes and Exosomal CCL2 mRNA as Biomarkers of Active Histologic Injury in IgA Nephropathy.
    Feng Y, Lv LL, Wu WJ, Li ZL, Chen J, Ni HF, Zhou LT, Tang TT, Wang FM, Wang B, Chen PS, Crowley SD, Liu BC.
    Am J Pathol; 2018 Nov 30; 188(11):2542-2552. PubMed ID: 30142333
    [Abstract] [Full Text] [Related]

  • 35. Value of urinary levels of interleukin-6, epidermal growth factor, monocyte chemoattractant protein type1 and transforming growth factor β1 in predicting the extent of fibrosis lesions in kidney biopsies of patients with IgA nephropathy.
    Segarra-Medrano A, Carnicer-Caceres C, Valtierra-Carmeno N, Agraz-Pamplona I, Ramos-Terrades N, Jatem Escalante E, Ostos-Roldan E.
    Nefrologia; 2017 Nov 30; 37(5):531-538. PubMed ID: 28946966
    [Abstract] [Full Text] [Related]

  • 36. Correlation Between Kappa Prozone Effect and IgA Kappa M Proteins in Serum Free Light-Chain Assay.
    Turner KA, Eckelkamp LL, Kalass SJ, Martinez MA, Brewer HR, Hoyne JB, Snyder MR, Murray DL, Willrich MAV.
    Clin Chem; 2019 Oct 30; 65(10):1327-1329. PubMed ID: 31387883
    [No Abstract] [Full Text] [Related]

  • 37. Imaging mass spectrometry analysis reveals an altered lipid distribution pattern in the tubular areas of hyper-IgA murine kidneys.
    Kaneko Y, Obata Y, Nishino T, Kakeya H, Miyazaki Y, Hayasaka T, Setou M, Furusu A, Kohno S.
    Exp Mol Pathol; 2011 Oct 30; 91(2):614-21. PubMed ID: 21798258
    [Abstract] [Full Text] [Related]

  • 38. Electrophoretic methods for analysis of urinary polypeptides in IgA-associated renal diseases.
    Julian BA, Wittke S, Novak J, Good DM, Coon JJ, Kellmann M, Zürbig P, Schiffer E, Haubitz M, Moldoveanu Z, Calcatera SM, Wyatt RJ, Sýkora J, Sládková E, Hes O, Mischak H, McGuire BM.
    Electrophoresis; 2007 Dec 30; 28(23):4469-83. PubMed ID: 18004714
    [Abstract] [Full Text] [Related]

  • 39. Urinary peptidome analysis in CKD and IgA nephropathy.
    Li Z, Zeng N, Zhao X, Chen X, Liang G, Liu H, Lin J, Zheng P, Lin X, Zhou H, Zheng D.
    Clin Kidney J; 2023 Nov 30; 16(11):1965-1973. PubMed ID: 37915931
    [Abstract] [Full Text] [Related]

  • 40. [Prognostic values of serum concentration and urinary excretion of interleukin-1 receptor antagonist and tumor necrosis factor receptors type I and II in patients with IGA nephropathy].
    Zwiech R, Kacprzyk F, Szuflet A, Nowicki M.
    Pol Arch Med Wewn; 2005 Apr 30; 113(4):326-33. PubMed ID: 16209246
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.